Internal Medicine, Endocrinology, Diabetes, & Metabolism · Columbia, SC
NPI
1336434182
Since 2011
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
2 Medical Park Road, Suite 506
Columbia, SC, 29203
Phone (803) 434-3930
Groups this clinician bills Medicare through
Medicare paid, 2024
$54K
2,553 services
Medicare patients, 2024
292
Average age 69
Drug cost, 2024
$4.1M
3,060 prescriptions
Company payments, 2025
$1,517
From 21 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Brooke S McAdams was code 99214 (office e&m - established), 303 times for 210 patients. In total Brooke S McAdams billed 2,553 services in 21 codes, and Medicare paid $54K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-08-01.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 303 | 210 | $86.06 | $26K |
| 83036 Blood Count | Office | 191 | 114 | $8.96 | $1,711 |
| 99215 Office E&M - Established | Office | 126 | 87 | $124.73 | $16K |
| 82947 Clinical Chemistry | Office | 122 | 86 | $3.69 | $450 |
| 95251 Test - Miscellaneous | Office | 117 | 64 | $24.74 | $2,895 |
| 99213 Office E&M - Established | Office | 38 | 37 | $58.19 | $2,211 |
| 99223 Hospital E&M - Initial | Facility | 13 | 12 | $138.78 | $1,804 |
By year: 2022 $58K for 2,165 services; 2023 $56K for 4,991 services; 2024 $54K for 2,553 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83036 Blood Count | 191 | 114 | $8.96 | $1,711 |
| 82947 Clinical Chemistry | 122 | 86 | $3.69 | $450 |
Medicare prescription drug claims, 2024
In 2024, the drug Brooke S McAdams prescribed most often to Medicare patients was Levothyroxine Sodium, with 282 prescriptions and refills. In total Brooke S McAdams wrote 3,060 Medicare prescriptions that cost $4.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 282 | 838 | 95 | $4,762 |
| Ozempic Semaglutide | 247 | 422 | 56 | $403K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 104 | 227 | 42 | $12K |
| Trulicity Dulaglutide | 92 | 155 | 24 | $151K |
| Mounjaro Tirzepatide | 91 | 132 | 23 | $139K |
| Jardiance Empagliflozin | 89 | 181 | 25 | $103K |
| Omnipod 5 Dexg7g6 Pods (Gen 5) Insulin Pump Cart,auto,bt,g6/7 | 83 | 163 | 23 | $97K |
| Methimazole Generic | 75 | 208 | 24 | $632 |
| Toujeo Max Solostar Insulin Glargine,hum.Rec.Anlog | 74 | 164 | 28 | $79K |
| Metformin Hcl Generic | 73 | 203 | 28 | $622 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 69 | 137 | 27 | $10K |
| Synthroid Levothyroxine Sodium | 64 | 158 | 19 | $6,018 |
| Metformin Hcl Er Metformin Hcl | 50 | 127 | 18 | $1,020 |
| Tresiba Flextouch U-200 Insulin Degludec | 49 | 112 | 16 | $77K |
| Humalog Kwikpen U-200 Insulin Lispro | 46 | 75 | 15 | $46K |
Brand drugs: 1,620 claims; generic drugs: 1,130 claims; opioid claims: 12.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Brooke S McAdams $1,517 ($1,517 in general payments such as food, travel and fees) from 21 companies. The largest payer was Xeris Pharmaceuticals, Inc. with $166.
| Company | Payments | Amount |
|---|---|---|
| Xeris Pharmaceuticals, Inc. | 8 | $166 |
| Corcept Therapeutics CORT | 7 | $160 |
| Medtronic, Inc. MDT | 5 | $120 |
| Sequel Med Tech, LLC | 4 | $98.71 |
| RGH Enterprises LLC | 1 | $91.44 |
| Tandem Diabetes Care, Inc. TNDM | 4 | $89.25 |
| Beta Bionics, Inc. BBNX | 3 | $84.92 |
| Sanofi-Aventis U.S. LLC SNY | 3 | $79.88 |
| Insulet Corporation PODD | 3 | $78.57 |
| Ascendis Pharma Endocrinology Inc ASND | 3 | $74.66 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.